The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor derived cell-free DNA (ctDNA) to predict recurrence of metastatic colorectal cancer (mCRC) following curative intent surgery or radiation.
 
Bryant Chee
No Relationships to Disclose
 
Faaiz Ibrahim
No Relationships to Disclose
 
Mikaela Esquivel
No Relationships to Disclose
 
Emily E. Van Seventer
Employment - Blueprint Medicines
Stock and Other Ownership Interests - Blueprint Medicines
 
Joy X. Jarnagin
No Relationships to Disclose
 
Li Zhang
Consulting or Advisory Role - Dendreon; Fortis; Unity Biotechnology
Travel, Accommodations, Expenses - Dendreon; Dendreon; Dendreon
 
Jin Hyun Ju
Employment - Guardant Health; Illumina
Stock and Other Ownership Interests - Abbvie; AstraZeneca; Guardant Health; Illumina; Immunogen; Immunogen; InVitae; Merck; Pfizer; Seagen; Seer; Viking Therapeutics; xenon pharma; Zymeworks
 
Kristin Sedgwick Price
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Victoria M. Raymond
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health; Trovagene
 
Carlos U. Corvera
No Relationships to Disclose
 
Kenzo Hirose
No Relationships to Disclose
 
Eric K. Nakakura
No Relationships to Disclose
 
Katherine Van Loon
Speakers' Bureau - Amgen; Physicans' Education Resource
Research Funding - Celgene (Inst)
 
Ryan Bruce Corcoran
Stock and Other Ownership Interests - Avidity Biosciences; C4 Therapeutics; Fount Therapeutics; Kinnate Biopharma; nRichDx; Revolution Medicines
Consulting or Advisory Role - Abbvie; Amgen; Array BioPharma; Asana Biosciences; Astex Pharmaceuticals; Avidity Nanomedicines; Bristol-Myers Squibb; C4 Therapeutics; Chugai Pharma; Elicio Therapeutics; FOGPharma; Fount Therapeutics; Genentech; Ipsen; Kinnate Biopharma; Loxo; Merrimack; N-of-One; Natera; Novartis; nRichDx; Revolution Medicines; Roche; Roivant; Shionogi; Shire; Spectrum Pharmaceuticals; Symphogen; Taiho Pharmaceutical; Warp Drive Bio; Zikani Therapeutics
Research Funding - Asana Biosciences; AstraZeneca; Lilly; Sanofi
 
Aparna Raj Parikh
Consulting or Advisory Role - Foundation Medicine; Lilly; Natera; PureTech
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Guardant Health (Inst); Lilly (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Plexxikon (Inst); Tesaro (Inst)
 
Chloe Evelyn Atreya
Stock and Other Ownership Interests - Pionyr
Consulting or Advisory Role - Array BioPharma; Pionyr
Research Funding - Bristol-Myers Squibb; Genentech (Inst); Guardant Health; Merck; Novartis
Travel, Accommodations, Expenses - Roche